These higher levels of 3-hydroxy-kynurenine could reflect a higher activation of indoleamine 2,3-dioxygenase 1 (IDO1) in the kynurenine pathway within the clonal PCs of MM compared to MGUS. This evidence concerns the gene IDO1 and Miyoshi myopathy.